{
  "created_at": "2020-07-16T05:12:56.000Z",
  "updated_at": "2021-01-06T08:25:01.106Z",
  "id": "a2da1f9e-979a-40e0-a8f0-b7a2820cf345",
  "labels": "current-affairs,2020-07-17",
  "question": "Which state is to launch a trial to study the efficacy of BCG vaccine in reducing Covid-19 mortality on elder people?",
  "option1": "Kerala",
  "option2": "Tamil Nadu",
  "option3": "Karnataka",
  "option4": "Andhra Pradesh",
  "option5": "",
  "answer": "Tamil Nadu",
  "explanation": "The state of Tamil Nadu is set to launch a trial to study the efficacy of the BCG vaccine in reducing mortality due to COVID-19 in the elder people.\r\nThe trial, which has been approved by the Indian Council of Medical Research (ICMR), would be taken up by the National Institute for Research in Tuberculosis (NIRT), Chennai. The BCG (Bacille Calmette-Guerin) is being administered to new-born for 50 years as a vaccine against tuberculosis."
}